On the prodrug potential of novel aldose reductase inhibitors with diphenylmethyleneaminooxycarboxylic acid structure

Author： Rakowitz D.   Matuszczak B.   Gritsch S.   Hofbauer P.   Krassnigg A.   Costantino L.  

Publisher： Elsevier

ISSN： 0928-0987

Source： European Journal of Pharmaceutical Sciences, Vol.15, Iss.1, 2002-02, pp. : 11-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thienocinnolinone Alkanoic Acid Derivatives as Aldose Reductase Inhibitors

By  

Medicinal Chemistry, Vol. 2, Iss. 1, 2006-01 ,pp. : 39-45

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Docking Studies of Novel Arylidene-2, 4-Thiazolidinediones as Potential Aldose Reductase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 7, 2013-08 ,pp. : 604-612

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Combined Pharmacophore Mapping and Quantitative Structure Selectivity Relationship Analysis for the Development of Potent and Selective Human Aldose Reductase Inhibitors

By  

Current Computer - Aided Drug Design, Vol. 9, Iss. 3, 2013-09 ,pp. : 371-384

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications

By Miyamoto Shuichi  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 5, 2002-05 ,pp. : 621-631

Informa Healthcare

Access to resources Recommend Favorite

Novel aldose reductase inhibitors: a patent survey (2006 – present)

By Chatzopoulou Maria   Alexiou Polyxeni   Kotsampasakou Eleni   Demopoulos Vassilis J  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 11, 2012-11 ,pp. : 1303-1323

Informa Healthcare

Access to resources Recommend Favorite